Mourad Gumusboga

Mourad Gumusboga is a Researcher in Mycobacteriology at the Institute of Tropical Medicine Antwerp (ITM). His research focuses on tuberculosis (TB) diagnosis, drug resistance mechanisms, and treatment regimens in low-income settings. He holds a Bachelor’s degree in an academic qualification not detailed here.

• Collaborates on projects funded by USAID and other agencies, including the Tuberculosis Implementation Framework Agreement (TIFA DRC) and TriDoRe (High-Dose TB Retreatment Regimens).
• Conducts studies on Mycobacterium tuberculosis, including diagnostic methods (e.g., tongue swab culture isolation) and drug resistance patterns in Mali, the Democratic Republic of the Congo, and other regions.
• Investigates strategies to combat acquired drug resistance during TB treatment and evaluates novel drugs like bedaquiline for resistant cases.

His work emphasizes global health challenges, particularly in Africa, and aims to improve TB treatment efficacy while minimizing resistance development. He has contributed to 24 research outputs since 2008, with recent articles addressing non-tuberculous mycobacteria prevalence and treatment regimen optimization.